Arvinas, Inc. (NASDAQ:ARVN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 11, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.63, ...
Edible Garden Rolls Out Zero-Waste Inspired® Curb-Side Sustainable Pots
New packaging solution ensures all take-home products are recyclable through most curb-side programsBELVIDERE, NJ, Feb. 13, ...
Genprex’s Oncoprex included in lung cancer therapy
Genprex’s (GNPX) research collaborators at a major cancer research center in Houston, Texas have published a new study which used the company’s ...
Science Daily21h
AI unlocks genetic clues to personalize cancer treatment
A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...
New Cancer Warning: Report Identifies DUSP2 Gene Deficiency As Key Factor
According to a recent study, Taiwanese researchers found that DUSP2 gene deficiency aids cancer cell growth, especially in ...
Leveraging a novel protein tagging strategy offers new route to cancer treatment
In a pioneering collaboration with AbbVie, Northwestern researchers have discovered a new way to potentially treat cancer by ...
Medindia17h
AI-Driven Genetics Paves the Way for Personalized Cancer Treatment
The research uncovers key genetic mutations that affect cancer treatment responses and develops a predictive tool for ...
pharmaphorum23h
ASCO: KRAS upstarts set their sights on NSCLC market
There are already two drugs on the market targeting KRAS mutations, for decades considered an undruggable target, but no shortage of drug candidates hoping to follow them. At ASCO, Eli Lilly ...